Anzeige
Meldung des Tages: Germanium & Gallium: Ein US-Projekt rückt nach dieser News jetzt in den Fokus – mitten in Nevada

Curatis Aktie News

Aktie
WKN:  A40BDL ISIN:  CH1330780979 Branche:  Pharmazeutika Land:  Schweiz
12,85 CHF
+0,85 CHF
+7,08%
13,839 € 12:41:52 Uhr
Depot/Watchlist
Marktkapitalisierung *
59,05 Mio. €
Streubesitz
22,26%
KGV
-14,67
Index-Zuordnung
-

Curatis News

21.11.25 - EQS
Curatis Holding AG announces CHF 1.2 million private placement with strategic investor
Curatis Holding AG / Key word(s): Agreement/Financing Curatis Holding AG announces CHF 1.2 million private placement with strategic investor 21-Nov-2025 / 07:00 CET/CEST ...
18.09.25 - EQS
FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3
Curatis Holding AG / Key word(s): Miscellaneous FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3 18.09.2025 / 07:00 ...
15.09.25 - EQS
Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01
Curatis Holding AG / Key word(s): Half Year Results Curatis: Double-​digit growth in core business and development milestone achieved for C-PTBE-01 15-Sep-2025 / 07:00 ...
05.09.25 - EQS
Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues
Curatis Holding AG / Key word(s): Agreement/Incoming Orders Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues 05.09.2025 / ...
31.07.25 - EQS
FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study
Curatis Holding AG / Key word(s): Legal Matter/Strategic Company Decision FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study 31.07.2025 / 06:00 CET/CEST
24.05.25 - EQS
Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Curatis Holding AG / Key word(s): AGMEGM Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors 24.05.2025 / 11:31 CET/CEST
23.05.25 - EQS
Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE expected to exceed USD 1 billion | Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog
Curatis Holding AG / Key word(s): Change in Forecast/Strategic Company Decision Curatis discloses Corticorelin as active substance of C-PTBE-01 | Market Opportunity in PTBE ex...
27.03.25 - EQS
Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe beim Lead-Projekt C-PTBE-01
Curatis Holding AG / Key word(s): Annual Results/Strategic Company Decision Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe ...
11.03.25 - EQS
Curatis Announces Formation of Distinguished Advisory Board
Curatis Holding AG / Key word(s): Strategic Company Decision Curatis Announces Formation of Distinguished Advisory Board 11.03.2025 / 07:00 CET/CEST

Newssuche

Videos

newspaper
10:20 Uhr +8,79%
Technical Trading: DAX Long Setup
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »